| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/06/2005 | US20050222778 System, method, and computer-readable medium for collection of environmental data and generation of user report for compliance with FDA requirements |
| 10/06/2005 | US20050222777 System, method, and computer software prorduct for specifying parameters associated with a biological probe array |
| 10/06/2005 | US20050222776 Method for fragment preparation |
| 10/06/2005 | US20050222501 Multivariate analysis of green to ultraviolet spectra of cell and tissue samples |
| 10/06/2005 | US20050222399 Bioinformatically detectable group of novel regulatory oligonucleotides associated with alzheimer's disease and uses thereof |
| 10/06/2005 | US20050222390 The peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases |
| 10/06/2005 | US20050222389 Method for preparing modified polypeptides |
| 10/06/2005 | US20050222235 Drugs for improving the prognosis of brain injury and a method of screening the same |
| 10/06/2005 | US20050222218 Screening method and compounds for treating friedreich ataxia |
| 10/06/2005 | US20050222096 Drug screening for modulators having aspirin activity but not thrombin activatable fibrinolysis inhibitory activity; ortho-hydroxybenzamides; anticoagulants |
| 10/06/2005 | US20050222074 Modulators of bone homeostasis identified in a high-throughput screen |
| 10/06/2005 | US20050222062 Decoy for treating and/or preventing th2 cytokine-associated allergic disease, gata3 mutant protein and medicinal compositions containing the same |
| 10/06/2005 | US20050222061 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 10/06/2005 | US20050222029 Compositions and methods for treating diseases |
| 10/06/2005 | US20050222022 administering to a mammal stem cell factor in an amount sufficient to induce neuroproliferation from endogenous cells, can induce migration of stem cells to neural tissue and/or induce proliferation and/or differentiation of such cells into neurons |
| 10/06/2005 | US20050221510 Surface modification of metals for biomolecule detection using surface enhanced Raman scattering (SERS) |
| 10/06/2005 | US20050221509 Surface modification of metals for biomolecule detection using surface enhanced Raman scattering (SERS) |
| 10/06/2005 | US20050221508 Surface modification of metals for biomolecule detection using surface enhanced Raman scattering (SERS) |
| 10/06/2005 | US20050221507 Method to detect molecular binding by surface-enhanced Raman spectroscopy |
| 10/06/2005 | US20050221506 Surface modification of metals for biomolecule detection using surface enhanced Raman scattering (SERS) |
| 10/06/2005 | US20050221505 Optoelectronic rapid diagnostic test system |
| 10/06/2005 | US20050221504 Diagnostic test kit can be inexpensively manufactured for disposable or single-use applications; photodetector generates an electrical signal representing a measurement of light from a test region on a medium such as a lateral-flow strip for a binding assay |
| 10/06/2005 | US20050221503 Plasmonic and/or microcavity enhanced optical protein sensing |
| 10/06/2005 | US20050221502 for selective precipitation of VLDL, chylomicrons and immunoseparation of HDL from a blood fluid sample; allows the assay to be performed entirely in a flow strip format |
| 10/06/2005 | US20050221501 Dissolution method |
| 10/06/2005 | US20050221500 Protein identification from protein product ion spectra |
| 10/06/2005 | US20050221499 has multi function: as a dye (i.e. a hardness indicator), as a pH buffer, as a masking reagent, as a titrant solution and so on; Eriochrome Black T (EBT) and Calmagite; triethanolamine; a glycol compound; and a pH buffer |
| 10/06/2005 | US20050221498 Quantitative method of determining beryllium or a compound thereof in a sample |
| 10/06/2005 | US20050221497 Quality control method |
| 10/06/2005 | US20050221496 Quality control method |
| 10/06/2005 | US20050221495 Method and composition for improving NMR analysis of formation fluids |
| 10/06/2005 | US20050221473 Sensor array integrated circuits |
| 10/06/2005 | US20050221470 accommodated in a wrapping member for providing an analytical tool pack and caused to project from the wrapping member in use, the analytical tool pack including a stopper portion for holding the analytical tool; opening and pushing machanism; for diabetics |
| 10/06/2005 | US20050221469 Extracellular potential measuring device and its manufacturing method |
| 10/06/2005 | US20050221462 (3R)-Hydroxymyristoyl-(acyl-carrier-protein) dehydratase mixture for identifying modulators for prevention/treating bacterial infection; bactericides; microbiocides |
| 10/06/2005 | US20050221459 Geranylgeranyl transferase type I (GGTase-I) structure and uses thereof |
| 10/06/2005 | US20050221445 Useful as agents that inhibit virus infection of cells |
| 10/06/2005 | US20050221440 Nucleic acid containing a reading frame with a first sequence encoding segments of the tumor associated antigen, PRAME (preferentially expressed antigen in melanoma); immunogenic; cluster sequences have affinity for a same Major Histocompatibility Complex receptor peptide binding cleft |
| 10/06/2005 | US20050221434 Receptor of the EDb-fibronectin domains |
| 10/06/2005 | US20050221420 Nogo receptor homologues and their use |
| 10/06/2005 | US20050221415 to eliminate influence of hemoglobin or degradation products for accurate measurement of analyte using a redox reaction; glycated hemoglobin in erythrocytes with hydrogen peroxide; leuco dye colorimetric analysis; 2,4-dinitroaniline; dodecylbenzenesulfonic acid sodium salt |
| 10/06/2005 | US20050221414 Kit for measuring the thrombin generation in a sample of a patient's blood or plasma |
| 10/06/2005 | US20050221413 Sulfenyl compound, labeling reagent, and method of analyzing peptide |
| 10/06/2005 | US20050221412 Probes for imaging protein phosphorylation and dephosphorylation and method for detecting and determining protein phosphorylation and dephosphorylation using the same |
| 10/06/2005 | US20050221408 Compositions and methods for detection of single molecules |
| 10/06/2005 | US20050221407 Method for detecting lysosomal storage diseases |
| 10/06/2005 | US20050221406 Method, composition and device for treating starch related diseases |
| 10/06/2005 | US20050221405 Combination in a medium (i) a sample suspected of containing buprenorphine (BUP) or norbuprenorphine (norBUP) and (ii) an antibody raised against an immunogen of buprenorphine (BUP) or norbuprenorphine (norBUP), medium is examined for the presence of a complex comprising a labeled hapten of buprenorphine |
| 10/06/2005 | US20050221404 Infective aggregating forms of proteins such as PrP, amyloid, and tau are bound selectively in the presence of the normal form protein using protease resistant binding agents such as dextran sulphate or pentosan |
| 10/06/2005 | US20050221401 Method of estimating risk of dental decay, apparatus of estimating risk of dental decay, system of estimating risk of dental decay and program of estimating risk of dental decay |
| 10/06/2005 | US20050221400 Monoclonal antibody comprising an antigen binding site that binds specifically to PSCA protein wherein monoclonal antibody comprises the amino acid sequence of the variable heavy chain region and the variable light chain region of antibody secreted by hybridoma assigned A.T.C.C. Accession No.: PTA-6697 |
| 10/06/2005 | US20050221399 Method for screening cervical cancer |
| 10/06/2005 | US20050221398 Protein expression profiling and breast cancer prognosis |
| 10/06/2005 | US20050221397 RM2 antigen (beta1,4-GalNAc-disialyl-Lc4) as prostate cancer-associated antigen |
| 10/06/2005 | US20050221396 Method for detection of malaria and other parasite infections |
| 10/06/2005 | US20050221395 Methods and products based on oligomerization of stress proteins |
| 10/06/2005 | US20050221394 Ion channel |
| 10/06/2005 | US20050221393 Method of increasing product expression through solute stress |
| 10/06/2005 | US20050221392 Detection and isolation of cell populations from muscle using antibodies to fa1/dlk1 |
| 10/06/2005 | US20050221391 Reagents and methods for identification of binding agents |
| 10/06/2005 | US20050221390 High quantum yield acridinium compounds and their uses in improving assay sensitivity |
| 10/06/2005 | US20050221388 Molecular interactions in hematopoietic cells |
| 10/06/2005 | US20050221387 Fluorescence analysis method using fluorescent-activating antibodies |
| 10/06/2005 | US20050221386 Chromatographic exclusion agglutination assay and methods of use thereof |
| 10/06/2005 | US20050221385 Pressure based mobility shift assays |
| 10/06/2005 | US20050221384 Combinatorial libraries of monomer domains |
| 10/06/2005 | US20050221383 Osteoarthritis biomarkers and uses thereof |
| 10/06/2005 | US20050221382 Stratification of patient populations having or suspected of having rheumatoid arthritis |
| 10/06/2005 | US20050221380 Method for determination of the responsiveness of an individual to mistletoe lectin |
| 10/06/2005 | US20050221379 Using automated single container reaction system to provide rapid, efficient means of detecting immunological interactions; immunoassay |
| 10/06/2005 | US20050221377 for purifying DNA, RNA, proteins (antigens and antibodies) or cells; biochips; kits; reactive ion etching |
| 10/06/2005 | US20050221372 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| 10/06/2005 | US20050221371 Diagnosis of diseases related to an alteration in the regulation or in the coding regions of the RBP-7 gene and for prognosis/diagnosis of an eventual treatment with agents acting on pathologies involving abnormal cell proliferation and/or abnormal cell differentiation. |
| 10/06/2005 | US20050221370 Systems and methods for ordering, performing, and reporting genetic screening |
| 10/06/2005 | US20050221368 Methods for identifying RNA binding compounds |
| 10/06/2005 | US20050221363 Universal shotgun assay |
| 10/06/2005 | US20050221362 Method for immobilizing nucleic acid and method for manufacturing biosensor using the same method |
| 10/06/2005 | US20050221361 Encoded carrier and a method of monitoring an encoded carrier |
| 10/06/2005 | US20050221357 Normalization of gene expression data |
| 10/06/2005 | US20050221356 Process for producing ligand binding protein with the use of cell-free protein synthesis system and utilization thereof |
| 10/06/2005 | US20050221351 Methods and devices for microarray image analysis |
| 10/06/2005 | US20050221350 Method for identifying immunoreactive peptides |
| 10/06/2005 | US20050221349 based on the use of "two-component conjugate" systems comprising a catalytic label and a substrate label; reagent kit; antibodies labelled with two DNA substrates and a DNA-dependent enzyme that modifies the DNA in a detectable process can be used to detect antigen for example |
| 10/06/2005 | US20050221348 Drug screening; using a collection of proteinaceous biomarkers ("AD biomarkers) which can be measured in peripheral biological fluid samples to aid in the diagnosis of neurodegenerative disorders |
| 10/06/2005 | US20050221347 Inhibitors of binding between proteins and macromolecular ligands |
| 10/06/2005 | US20050221346 May be used to detect the presence of a cancer or to evaluate the prognosis of a known disease |
| 10/06/2005 | US20050221344 Interferon-Like molecules and uses thereof |
| 10/06/2005 | US20050221343 Self-assembling split-fluorescent protein systems |
| 10/06/2005 | US20050221341 Sequence-based karyotyping |
| 10/06/2005 | US20050221340 Computer-directed assembly of a polynucleotide encoding a target polypetide |
| 10/06/2005 | US20050221339 Compartmentalised screening by microfluidic control |
| 10/06/2005 | US20050221336 Mutations in capillary morphogenesis gene-2 (CMG-2) and use thereof |
| 10/06/2005 | US20050221334 Tape stripping methods for analysis of skin disease and pathological skin state |
| 10/06/2005 | US20050221330 Glial cell line-derived neurotrophic factor (GDNF); nervous system disorders, autonomic nervous system, shingles, asthma, irritable bowel, inflammatory bowel, constipation, headache, arthritis, spinal cord injury, chronic back pain, hypertension, mucositis, diabetes, fibromyalgia, and wound healing |
| 10/06/2005 | US20050221329 Use of fluorescent molecular beacons in the detection of methylated nucleic acid |
| 10/06/2005 | US20050221328 Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
| 10/06/2005 | US20050221327 Detecting integrin alpha 10 chain expressing mesenchymal stem cells (MSC) for use in tissue repair and/or regeneration |
| 10/06/2005 | US20050221325 Detection of secreted polypeptides |
| 10/06/2005 | US20050221324 Genotoxicity analysis |
| 10/06/2005 | US20050221320 Method |